-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $26

Benzinga·02/06/2026 14:40:37
Listen to the news
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $8 to $26.